pathway that regulates neuronal morphology and conas development proceeds, CNS labeling persists and increases in intensity until the end of embryogenesis nectivity.
(data not shown and Figure 1B ). In addition, CYFIP is expressed at low levels throughout the embryo. Results
Cloning of CYFIP and Expression Profile CYFIP Strongly Accumulates in Axons of the CNS
In order to characterize the CYFIP protein, we developed throughout Development A full-length Drosophila CYFIP cDNA (accession number an anti-CYFIP antibody, which detects a single band of 145 kD in Western blot analysis on Drosophila Schneider AY017343; Schenck et al., 2001 ) was obtained by using two overlapping EST clones. To assess at which stage (S2) cell and embryonic extracts ( Figures 1C and 1D ). The size of the recognized protein corresponds to the CYFIP is expressed, we performed Northern blot analysis on poly(A) ϩ RNA from embryos, larvae, wandering predicted molecular weight (Schenck et al., 2001 ). To confirm that this band corresponds to CYFIP, we tranlarvae, pupae, and adults. CYFIP is present throughout the fly life cycle as a single transcript of around 4.5 kb siently overexpressed the full-length product in S2 cells; extracts of transfected cells contain higher levels of and is also abundant in adult ovaries ( Figure 1A ). Signal quantification and normalization against a loading conthe 145 kD product than nontransfected cells (data not shown). trol indicated that there are no major peaks of CYFIP expression at specific stages ( Figure 1A) . In situ hybridThe CYFIP embryonic profile follows that of the transcript. It is detectable by stage 11 in the CNS, by stage ization revealed that CYFIP is ubiquitously and highly expressed in embryos at precellular (data not shown) 13 in the gut ( Figure 1E ). Its levels in the CNS increase until the end of embryogenesis ( Figure 1F ). CYFIP is and cellular blastoderm stages ( Figure 1B, pression is detected at the midline ( Figures 1E and 1F , dylisomerase, for which no mutant strain is reported. To assess whether CYFIP mutants also affect CG6226 arrowheads). Finally, CYFIP also accumulates at the motor axon terminals, at the stage at which synaptogenesis expression, we performed in situ hybridization using CYFIP-and CG6226-specific probes on wt, EP(3)3267, is initiated. Double labeling with an antibody (anti-Fas II) recognizing synapses (Schuster et al., 1996) , and CYFIP 70.1 ( Figure 2C ). While CYFIP 5.2 is null for both genes that CYFIP is localized at the NMJ (Figures 1G-1J) .
Western blot analysis ( Figure 1D) and 5B).
Generation of CYFIP Null Mutants
The prominent axonal localization suggested a role for The analysis of the excision mutants allows us to conclude that loss of CYFIP induces lethality, which mostly the CYFIP in axonogenesis. To test this hypothesis, we generated CYFIP mutant flies. EP line (3)3267 harbors occurs during pupal life, the first morphological abnormalities being observed around 12 hours after puparium a transposon on the right arm of the third chromosome, at position 88F. The transposon is inserted within exon formation. Pupae progressively shrink within the puparium case before the head has everted (data not shown). 1 of the CYFIP gene, in its 5Ј-UTR (Figure 2A) . Southern blotting using an EP-specific probe on genomic DNA isolated from EP ( Figure 4A , panels 4Ac and 4Ad versus panels 4Aa and 4Ab). In the literature, the number of synaptic boutons has usually been used to characterize the size of synaptic terminals. In the case of CYFIP, this parameter cannot be used; synaptic boutons appear fused or CYFIP mutants exhibit about four to five times more (79% crossing frequency in null embryos, 10% in resbuds than wt or revertant terminals (7.8 versus 1.6 or 2.0, cued embryos; n ϭ 100). Moreover, early pupal lethality p Ͻ 0.001) ( Figure 4C ). Thus, the CYFIP NMJ presents an was completely rescued, and some animals reached overall immature aspect, likely due to a block in synapse differentiation. adulthood (2%; number of expected adults, n ϭ 400). Figure 6A ). Luciferase was neibut not in wandering larvae, in agreement with the observation that maternal contribution is generally no longer ther bound by GST nor by GST-dFMR1. Next, to confirm CYFIP-dFMR1 interaction, we immunoprecipitated endetectable at that stage. Based on the amount of protein present in null embryos, the amount of maternal contridogenous CYFIP from cytoplasmic extracts of S2 cells transiently overexpressing dFMR1. dFMR1 coimmunobution corresponds to 10%-15% of CYFIP expression in wt embryos ( Figure 5B) . precipitated with endogenous CYFIP. In contrast, no dFMR1 was found when an aliquot of the same extract To determine the importance of the maternal contribution, we used the FLP/ovo D system (Chou and Perrimon, was incubated with comparable amounts of rabbit IgG ( Figure 6B ). 1996) and generated homozygous CYFIP mutant clones within the germline of heterozygous females. Deletion
We also performed coimmunoprecipitation experiments to check for dRac1-CYFIP interaction ( Figure 6C ). of both maternal and zygotic CYFIP leads to variable but dramatically enhanced nervous system defects (Fig- We transfected S2 cells with flag-tagged dRac1 constructs carrying either the constitutively active mutation ure 5C, compare with Figures 3A and 3AЈ) and to embryonic lethality. These data indicate that the maternal con-V12 (dRac1V12) or the dominant-negative mutation N17 (dRac1N17) and precipitated the proteins via their flag tribution of CYFIP rescues nervous system defects and embryonic lethality.
tags. Endogenous CYFIP was found to coimmunopreci- cued the two phenotypes ( Figure 7E, asterisk) , while cooverexpression of an unrelated protein, ␤-gal, had no effect on the dRac1V12 phenotype. The observed CYFIP Antagonizes dRac1 and dFMR1 in the Eye To gain insights into the signaling cascade involving antagonistic interaction between dRac1 and CYFIP was subsequently confirmed by using a sensitized backdRac1, CYFIP, and dFMR1, we performed genetic interaction experiments. Since unbalance between gene ground. dRac1V12 overexpression in flies that carry only half a dose of CYFIP show a much stronger phenotype products that work in the same pathway often induces a mutant phenotype, we overexpressed the three genes compared to that observed in wt flies overexpressing dRac1V12 ( Figure 7F, asterisk) . Eyes are strongly rein the eye using the GMR-Gal4 driver. No effect on eye morphology upon CYFIP overexpression could be deduced in size and flattened. The entire posterior half of these eyes has lost ommatidia and is deformed; ommatected ( Figure 7B) . Overexpression of dRac1V12, on the other hand, caused a mild rough phenotype, indicative tidia in the rest of the eye are not distinct from each other. In summary, CYFIP overexpression suppresses of ommatidia misorganization, and complete loss of ommatidia in the posterior region ( Figure 7D, asterisk) .
the rough eye phenotype due to overexpression of con-flies carrying UAS-dRac1N17, the dominant-negative form of dRac1. As reported by Chang and Ready (2000), eye overexpression of dRac1N17 also induces a rough eye phenotype. Indeed, constitutively active and dominant-negative small GTPase mutants often produce similar rather than opposite phenotypes, as expected from molecules that have a cyclic mode of action (Luo, 2000) . In contrast to the strong interactions observed with the activated form of dRac1, we did not detect an influence of CYFIP dosage in this analysis (Figures 7G-7I) . The finding that overexpression of CYFIP cannot rescue the dRac1N17 overexpression phenotype is likely due to the inability of dRac1N17 to bind (see above) and activate its effector CYFIP. To further characterize the relationship among the three players, we also asked whether dRac1 and dFMR1 genetically interact. For this purpose, we overexpressed dFMR1 in genetic backgrounds of either elevated or reduced dRac1 levels. The latter was achieved by using a deficiency, Df(3L)Ar14-8, that uncovers dRac1 (Hu et al., 2001). Cooverexpressing dFMR1 and dRac1 has a more severe phenotype than overexpressing either of the two proteins ( Figure 7M versus 7D and 7J) . Eyes overexpressing dRac1 and dFMR1 appear narrowed and show large ommatidia that are reduced in number compared to wt. We also observed areas containing degenerating ommatidia. On the other hand, overexpressing dFMR1 in eyes that have half a dose of dRac1 partially rescues the mutant phenotypes observed in eyes that are wild-type for dRac1 and that overexpress dFMR1 ( Figure 7N versus 7J) .
Overexpression of dFMR1 affects eye morphology (sevenless-
In summary, the eye phenotype of flies overexpress- which has been previously reported for dRac1V12 (Kaufmann et al., 1998). In elav-dRac1V12 embryos, 29% of ISNb were arrested at the site of contact with ventral stitutively active Rac1, while loss of one dose of CYFIP enhances that phenotype.
CYFIP Antagonizes dRac1 and dFMR1

Gal4 driven expression. (B) UAS-CYFIP/TM3, (C) CYFIP/ϩ, (D) UASin the Nervous System
Rac1V12/TM3, (E) UAS-Rac1V12/UAS-CYFIP, (F) UAS-Rac1V12/ CYFIP, (G) UAS-Rac1N17/ϩ, (H) UAS-Rac1N17/UAS-CYFIP, (I) UAS-
To test whether the antagonistic dRac1-CYFIP and
longitudinal muscle 13 before reaching their final target, muscle 12 (see Table 1 , schematic illustration) (27% The same CYFIP allelic combinations were used with Here we present data indicating that the CYFIP adaptor came from the analysis of central axons. Neither emmolecule directly interacts with two classes of proteins bryos overexpressing dRac1V12 nor heterozygous that are involved in such processes. Understanding the CYFIP null embryos ever showed ectopic midline crossmolecular link between cytoskeleton reorganization and ing, whereas 8% of embryos overexpressing dRac1V12 local control of translation is an important topic, as it in heterozygous CYFIP background showed these axon will help us to elucidate the molecular bases of neuronal guidance errors (Table 1A) 
